Angiostrongyliasis parasite primarily resides in rodents, particularly rats, but can also infect snails, slugs, and other intermediate hosts. Human infection occurs through ingestion of contaminated intermediate hosts or food items, such as raw vegetables or fruits, contaminated with the parasite's larvae. Once ingested, the larvae migrate to the central nervous system, causing neurological symptoms ranging from headaches and stiff neck to more severe complications such as meningitis or encephalitis. Diagnosis is often challenging due to nonspecific symptoms, but can be confirmed through laboratory tests or imaging studies. Treatment typically involves supportive care and antiparasitic medications, although severe cases may require hospitalization. Prevention focuses on proper food hygiene practices and avoiding consumption of raw or undercooked intermediate hosts. Public awareness and education are crucial in endemic regions to minimize the risk of infection and improve early detection and management of angiostrongyliasis.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain